• A 83-01: ALK-5 Inhibitor Workflows for TGF-β Pathway Studies

  2026-06-25

  A 83-01 (ALK inhibitor) empowers researchers to dissect TGF-β signaling, enabling high-precision experimental control in EMT, fibrosis, and growth inhibition studies. This article details advanced workflows, optimization strategies, and troubleshooting insights, bridging recent breakthroughs in Smad3-dependent corneal fibrosis modeling.

• Hijacking ERAD for Selective Degradation of Transmembrane Pr

  2026-06-24

  Song et al. (2026) introduce ERAD-engaging chimeras (ERADECs), a small-molecule platform that harnesses the ER-associated degradation pathway to achieve selective and efficient degradation of transmembrane proteins. This innovation addresses longstanding challenges in targeted protein degradation, expanding experimental and therapeutic possibilities in cellular signaling and immunology.

• Ibuprofen as an Emerging Environmental Contaminant: Toxicolo

  2026-06-23

  Janet Jan-Roblero and Juan A. Cruz-Maya’s review advances understanding of ibuprofen’s role as an environmental contaminant, highlighting its toxicological effects on aquatic organisms and the challenges of its biodegradation. The paper synthesizes recent evidence on ibuprofen’s persistence and calls for improved strategies to mitigate its ecological impact.

• 4-Ethylphenyl Sulfate: Surface Adsorption Insights for Trans

  2026-06-23

  Explore the unique adsorption behavior of 4-ethylphenyl sulfate—a key microbiota-derived metabolite—on biomaterial surfaces. This article delivers in-depth analysis for researchers studying gut microbiota-brain interactions and renal dysfunction biomarkers.

• Palonosetron Hydrochloride: Specific 5-HT3 Receptor Antagoni

  2026-06-22

  Palonosetron hydrochloride is a highly selective 5-HT3 receptor antagonist with sub-nanomolar potency and minimal off-target effects. Its unique mechanism combines dual-site binding with prolonged receptor occupancy, supporting its use in chemotherapy-induced nausea and vomiting prevention. Quantitative benchmarks and protocol guidance make it a robust tool for cancer research and transporter biology.

• AO/PI Staining Solution: Precision Cell Viability for Transl

  2026-06-22

  Explore the advanced science behind AO/PI Staining Solution and its role in precise live/dead cell discrimination using fluorescent DNA dyes. This article delivers unique insights into optimizing cell viability assays for translational nephrology and inflammation research.

• Superoxide Dismutase (SOD) Activity Assay Kit: Technical Gui

  2026-06-21

  The Superoxide Dismutase (SOD) Activity Assay Kit enables fast, quantitative measurement of SOD enzyme activity in biological fluids using a colorimetric workflow. It is best suited for oxidative stress and antioxidative enzyme research, not for diagnostic or clinical use. Researchers should apply this kit in accordance with protocol guidance to ensure reliable data and avoid common pitfalls.

• nor-NOHA Acetate: Beyond Arginase Inhibition in Immune Metab

  2026-06-20

  Explore how nor-NOHA acetate advances cancer research by modulating arginine metabolism and immune signaling. This article provides an in-depth analysis of its mechanistic impact, practical applications, and the latest insights bridging metabolic and immunological pathways.

• Trelagliptin Succinate Enhances Insulin Sensitivity via PI-3

  2026-06-19

  This study elucidates how trelagliptin succinate, a DPP-4 inhibitor, improves insulin resistance in adipocytes by modulating the PI-3K/AKT/GLUT4 signaling pathway. The findings clarify molecular events underlying trelagliptin's effects and provide a mechanistic rationale for targeting phosphorylation-dependent processes in metabolic disease research.

• Palonosetron Hydrochloride: Mechanistic Insight to Clinical

  2026-06-19

  Palonosetron hydrochloride stands apart as a next-generation 5-HT3 receptor antagonist, offering translational researchers unprecedented mechanistic specificity and practical workflow advantages. This article provides an integrated, evidence-driven perspective on its allosteric activity, receptor selectivity, and clinical relevance in chemotherapy- and radiotherapy-induced nausea and vomiting, with actionable guidance for experimental deployment and future research directions.

• Azithromycin as a Senolytic Macrolide: Mechanistic Insights

  2026-06-18

  Explore the dual scientific utility of Azithromycin as a macrolide antibiotic—both as a bacterial protein synthesis inhibitor and as a senolytic agent targeting senescent cells. Uncover advanced applications, protocol parameters, and evidence-based differentiation for contemporary bacterial infection research and emerging aging assays.

• Sulfo-NHS-Biotin: Precision Protein Labeling for Surface Pro

  2026-06-18

  Sulfo-NHS-Biotin stands out as a water-soluble, amine-reactive reagent enabling highly selective cell surface protein labeling without membrane permeation. Its use in advanced workflows, such as affinity-based isolation and EV-targeted degradation, unlocks new experimental capabilities that standard biotinylation reagents cannot match.

• Diethylmaleate: Transforming Redox Biology & Resistance Rese

  2026-06-17

  Discover how Diethylmaleate, a gold-standard glutathione-depleting reagent, is redefining oxidative stress modeling and resistance studies. This thought-leadership article bridges mechanistic evidence from recent research on GST-mediated pesticide resistance with actionable strategies for translational and toxicology researchers, highlighting protocol design, cross-domain insights, and the compound’s unique value as an intracellular glutathione modulator.

• CLCC1 Identified as Key Host Factor in Herpesvirus Nuclear E

  2026-06-17

  A recent study reveals CLCC1 as an essential host mediator of nuclear membrane fusion during herpesvirus egress, resolving a longstanding question in virology. This discovery advances our understanding of viral-host interactions and nuclear envelope dynamics, with implications for broader cell biology and antiviral research.

• SB 202190: Precision Tool for Dissecting p38 MAPK in Cancer

  2026-06-16

  This thought-leadership article unpacks the mechanistic and strategic advances enabled by SB202190 (FHPI) in translational research, with a focus on tumor immunology and organoid modeling. We bridge evidence from recent colorectal cancer studies with practical experimental guidance, highlight the unique role of APExBIO's SB202190 versus standard inhibitors, and provide actionable recommendations for researchers aiming to drive next-generation inflammation and cancer therapeutics.

483 records 9/33 page Previous Next First page 上5页 678910 下5页 Last page